Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial

Yardley, Denise A and Brufsky, Adam and Coleman, Robert E and Conte, Pierfranco F and Cortes, Javier and Glück, Stefan and Nabholtz, Jean-Mark A and O’Shaughnessy, Joyce and Beck, Robert M and Ko, Amy and Renschler, Markus F and Barton, Debora and Harbeck, Nadia (2015) Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial. Trials, 16 (1).

Preview	PDF Published Version Available under License : See the attached license file. Download (870kB) | Preview
	Plain Text (licence) Available under License : See the attached license file. Download (1kB)

---

Share

Citation/Export:	Select format... Citation - Text Citation - HTML Endnote BibTex Dublin Core OpenURL MARC (ISO 2709) METS MODS EP3 XML Reference Manager Refer
Social Networking:	Share |

---

Details

Item Type:	Article
Status:	Published
Creators/Authors:	Creators Email Pitt Username ORCID Yardley, Denise A Brufsky, Adam adb5@pitt.edu ADB5 Coleman, Robert E Conte, Pierfranco F Cortes, Javier Glück, Stefan Nabholtz, Jean-Mark A O’Shaughnessy, Joyce Beck, Robert M Ko, Amy Renschler, Markus F Barton, Debora Harbeck, Nadia
Date:	December 2015
Date Type:	Publication
Journal or Publication Title:	Trials
Volume:	16
Number:	1
Publisher:	Springer Science and Business Media LLC
DOI or Unique Handle:	10.1186/s13063-015-1101-7
Schools and Programs:	School of Medicine > Medicine
Refereed:	Yes
Date Deposited:	18 Aug 2016 19:54
Last Modified:	05 Aug 2020 00:55
URI:	http://d-scholarship.pitt.edu/id/eprint/28937

---

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com

---

Actions (login required)

View Item